17.98 USD
+0.1 (+0.56%)
18.09 USD
+0.11 (+0.61%)
We assign a fundamental rating of 3 out of 10 to SDGR. SDGR was compared to 35 industry peers in the Health Care Technology industry. While SDGR has a great health rating, there are worries on its profitability. While showing a medium growth rate, SDGR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SDGR had negative earnings in the past year.
SDGR had a negative operating cash flow in the past year.
In the past 5 years SDGR reported 4 times negative net income.
In the past 5 years SDGR reported 4 times negative operating cash flow.
1.2 Ratios
SDGR has a Return On Assets of -26.92%. This is comparable to the rest of the industry: SDGR outperforms 42.86% of its industry peers.
SDGR's Return On Equity of -54.77% is in line compared to the rest of the industry. SDGR outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.92% | ||
| ROE | -54.77% | ||
| ROIC | N/A |
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 58.16%, SDGR is in line with its industry, outperforming 48.57% of the companies in the same industry.
SDGR's Gross Margin has improved in the last couple of years.
SDGR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 58.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SDGR has been increased compared to 1 year ago.
The number of shares outstanding for SDGR has been increased compared to 5 years ago.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SDGR has an Altman-Z score of 1.11. This is a bad value and indicates that SDGR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.11, SDGR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.11 |
ROIC/WACCN/A
WACC9.65%
2.3 Liquidity
SDGR has a Current Ratio of 3.25. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.25, SDGR is doing good in the industry, outperforming 71.43% of the companies in the same industry.
A Quick Ratio of 3.25 indicates that SDGR has no problem at all paying its short term obligations.
SDGR has a better Quick ratio (3.25) than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.25 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.82% over the past year.
Looking at the last year, SDGR shows a very strong growth in Revenue. The Revenue has grown by 32.90%.
Measured over the past years, SDGR shows a quite strong growth in Revenue. The Revenue has been growing by 19.41% on average per year.
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
3.2 Future
Based on estimates for the next years, SDGR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.75% on average per year.
SDGR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.77% yearly.
EPS Next Y19.11%
EPS Next 2Y17.98%
EPS Next 3Y16.62%
EPS Next 5Y13.75%
Revenue Next Year24.45%
Revenue Next 2Y22.44%
Revenue Next 3Y19.21%
Revenue Next 5Y19.77%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SDGR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SDGR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SDGR's earnings are expected to grow with 16.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.98%
EPS Next 3Y16.62%
5. Dividend
5.1 Amount
SDGR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
17.98
+0.1 (+0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners109.2%
Inst Owner Change0%
Ins Owners2.64%
Ins Owner Change-0.02%
Market Cap1.32B
Revenue(TTM)256.95M
Net Income(TTM)-175.99M
Analysts80
Price Target27.77 (54.45%)
Short Float %14.91%
Short Ratio9.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.11%
Min EPS beat(2)24.66%
Max EPS beat(2)37.55%
EPS beat(4)2
Avg EPS beat(4)6.54%
Min EPS beat(4)-28.59%
Max EPS beat(4)37.55%
EPS beat(8)5
Avg EPS beat(8)6.18%
EPS beat(12)8
Avg EPS beat(12)16.99%
EPS beat(16)10
Avg EPS beat(16)13.2%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.23%
Max Revenue beat(2)3.3%
Revenue beat(4)4
Avg Revenue beat(4)4.36%
Min Revenue beat(4)3.23%
Max Revenue beat(4)6.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)7
Avg Revenue beat(12)1.23%
Revenue beat(16)11
Avg Revenue beat(16)6.23%
PT rev (1m)1.2%
PT rev (3m)-3.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)21.94%
EPS NY rev (1m)0%
EPS NY rev (3m)12.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.12 | ||
| P/tB | 4.18 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.41
EYN/A
EPS(NY)-1.56
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS3.49
BVpS4.36
TBVpS4.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.92% | ||
| ROE | -54.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 58.16% | ||
| FCFM | N/A |
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 35.82% | ||
| Cap/Sales | 0.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 1.11 |
F-Score3
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
EPS Next Y19.11%
EPS Next 2Y17.98%
EPS Next 3Y16.62%
EPS Next 5Y13.75%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
Revenue Next Year24.45%
Revenue Next 2Y22.44%
Revenue Next 3Y19.21%
Revenue Next 5Y19.77%
EBIT growth 1Y21.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.65%
EBIT Next 3Y18.28%
EBIT Next 5YN/A
FCF growth 1Y97.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.1%
OCF growth 3YN/A
OCF growth 5YN/A
SCHRODINGER INC / SDGR FAQ
What is the ChartMill fundamental rating of SCHRODINGER INC (SDGR) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SDGR.
What is the valuation status for SDGR stock?
ChartMill assigns a valuation rating of 0 / 10 to SCHRODINGER INC (SDGR). This can be considered as Overvalued.
What is the profitability of SDGR stock?
SCHRODINGER INC (SDGR) has a profitability rating of 1 / 10.